Home
>
National Drug Code (NDC)
>
Levocetirizine dihydrochloride
Levocetirizine dihydrochloride - 45802-594-65 - (Levocetirizine dihydrochloride)
Drug Information of Levocetirizine dihydrochloride
| Product NDC: | 45802-594 |
| Proprietary Name: | Levocetirizine dihydrochloride |
| Non Proprietary Name: | Levocetirizine dihydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Levocetirizine dihydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Levocetirizine dihydrochloride
| Product NDC: | 45802-594 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090229 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20101126 |
Package Information of Levocetirizine dihydrochloride
| Package NDC: | 45802-594-65 |
| Package Description: | 30 TABLET in 1 BOTTLE (45802-594-65) |
NDC Information of Levocetirizine dihydrochloride
| NDC Code | 45802-594-65 |
| Proprietary Name | Levocetirizine dihydrochloride |
| Package Description | 30 TABLET in 1 BOTTLE (45802-594-65) |
| Product NDC | 45802-594 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Levocetirizine dihydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101126 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
